Post-acute COVID-19 sequelae, commonly known as long COVID, encompasses a range of
systemic symptoms experienced by a significant number of COVID-19 survivors. The …

The COVID-19 pandemic has resulted in upwards of 6.8 million deaths over the past three
years, and the frequent emergence of variants continues to strain global health. Although …

Long COVID-19 has been defined as the condition occurring in individuals with a history of
probable or confirmed SARS-CoV-2 infection, with related symptoms lasting at least 2 …

This case presents a patient with severe COVID-19 pneumonia requiring intensive care unit
admission and a prolonged hospital stay. The infection resulted in long-term morbidity …

Background Previous studies have suggested that respiratory virus infections may be
associated with new-onset asthma. However, whether coronavirus disease 2019 (COVID …

Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

Background Pulmonary fibrosis is characterized by lung parenchymal destruction and can
increase morbidity and mortality. Pulmonary fibrosis commonly occurs following …

Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease with no known
cure, characterized by the formation of scar tissue in the lungs, leading to respiratory failure …

The Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) and its sublineages pose a new challenge to healthcare …